Workflow
Bristol Myers Squibb to Report Results for Third Quarter 2025 on October 30, 2025
Businesswire· 2025-09-19 10:59
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Report Results for Third Quarter 2025 on October 30, 2025. ...
SBI Foundation to support 23,230 meritorious students under Asha Scholarship; commits ₹90 crore
BusinessLine· 2025-09-19 10:58
SBI Foundation, the CSR arm of the State Bank of India (SBI), has launched the SBI Platinum Jubilee Asha Scholarship 2025, with a commitment of ₹90 crore in FY26. India’s largest bank, in a statement, said this year the SBI Asha Scholarship, which was instituted in 2022, will empower 23,230 meritorious students from humble and underprivileged backgrounds across India, making higher education accessible to them.The scholarship covers students from Class 9 onwards up to postgraduate programmes, offering finan ...
Why Is Crypto Down Today? – September 19, 2025
Yahoo Finance· 2025-09-19 10:57
The crypto market is down today, with the global market cap falling by 0.8% to $4.17 trillion. Trading volume is also lower, now sitting at $143.7 billion. Most of the top cryptocurrencies are showing red on the 24-hour chart. TLDR: 8 of the top 10 cryptocurrencies are in the red today; BTC is down 0.6% to $116,601, ETH drops 1.6% to $4,522; CryptoQuant analyst expects BTC consolidation for 1–2 weeks; Michigan advances Bitcoin Reserve Bill (HB 4087); Bitunix says the bill boosts risk appetite sho ...
U.S. hotel results for week ending 13 September
Hospitality Net· 2025-09-19 10:57
ARLINGTON, Va. – The U.S. hotel industry reported mostly negative year-over-year comparisons, according to CoStar’s latest data through 13 September. CoStar is a leading global provider of online real estate marketplaces, information and analytics in the property markets.7-13 September 2025 (percentage change from comparable week in 2024):Occupancy: 65.4% (-1.8%)Average daily rate (ADR): US$162.71 (+0.1%)Revenue per available room (RevPAR): US$106.43 (-1.7%)Among the Top 25 Markets, Anaheim registered the s ...
4 Smart Moves for Retirees Ahead of the Social Security Overhaul
Yahoo Finance· 2025-09-19 10:56
The Social Security Administration now projects insolvency for its OASI Trust Fund by late 2032, after spending has accelerated under the One, Big Beautiful Bill Act. That means something will have to give over the next seven years. The government could trim benefits, raise the retirement age for benefits, raise taxes — or likely a combination of all three. Trending Now: Social Security’s Biggest Lie — Why ‘Full Retirement Age’ Isn’t What You Think Consider This: 6 Popular SUVs That Aren't Worth the Cost ...
Strength Seen in Luxfer (LXFR): Can Its 5.4% Jump Turn into More Strength?
ZACKS· 2025-09-19 10:55
Company Overview - Luxfer Holdings PLC (LXFR) shares increased by 5.4% to $14.77 in the last trading session, with a notable trading volume, and have gained 12.5% over the past four weeks [1] Market Performance - The recent rally in Luxfer's stock is attributed to positive sentiment regarding its strong performance in commercial and defense markets, driven by solid demand for products like magnesium powders and aerospace cylinders [2] - Additionally, increased sales of Meals Ready to Eat (MREs) and Group Rations (UGR-E) are contributing positively to the company's performance [2] Financial Expectations - Luxfer is projected to report quarterly earnings of $0.25 per share, reflecting a year-over-year decline of 10.7%, with expected revenues of $97 million, down 2.4% from the same quarter last year [3] Earnings Estimate Trends - The consensus EPS estimate for Luxfer has remained unchanged over the past 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4][5] - The stock currently holds a Zacks Rank of 2 (Buy), suggesting a favorable outlook [5] Industry Comparison - Luxfer is part of the Zacks Manufacturing - General Industrial industry, where another company, Helios Technologies (HLIO), also showed positive performance, finishing 3.7% higher at $55.61 [5] - Helios Technologies has a consensus EPS estimate of $0.64 for its upcoming report, representing an 8.5% increase from the previous year, and holds a Zacks Rank of 1 (Strong Buy) [6]
Paris-based Juisci raises €5.5 million to transform how healthcare professionals access scientific knowledge
EU· 2025-09-19 10:51
France’s Juisci, a HealthTech startup that transforms the way healthcare professionals consume scientific knowledge, has secured €5.5 million in Seed funding in order to boost R&D, scale its team, and accelerate international expansion, with a strong focus on the U.S. market.The round was led by Big Pi Ventures, with participation from Ring Capital, Bpifrance, and strategic business angels.“Doctors don’t need more information – they need quick, trustworthy access to science. Juisci gives them back time and ...
CAC 40 Modestly Higher; Stellantis, ArcelorMittal Among Top Gainers
RTTNews· 2025-09-19 10:51
French stocks are up in positive territory on Friday with investors mostly making cautious moves, assessing recent policy announcements from central banks, and continuing to weigh the potential impact of tariffs on economic growth. The benchmark CAC 40, which advanced to 7,934.92 earlier, was up 27.36 points or 0.35% at 7,881.97 a few minutes ago. Stellantis is rising 3.2%. ArcelorMittal is gaining nearly 3%, while Renault, BNP Paribas and Kering are up 1.6 to 1.7%.Credit Agricole and Societe Generale are ...
Mirion Technologies (MIR) Surges 8.4%: Is This an Indication of Further Gains?
ZACKS· 2025-09-19 10:51
Mirion Technologies, Inc. (MIR) shares soared 8.4% in the last trading session to close at $24.6. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 12.2% gain over the past four weeks.This increased investor optimism is mostly due to a combination of positive analyst ratings, stronger-than-expected quarterly results, and increased financial guidance for the year.This company is expected to post quarterly earnings of $0.11 per share ...
Merck Receives Positive EU CHMP Opinion for ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) in Infants During Their First RSV Season
Businesswire· 2025-09-19 10:50
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Receives Positive EU CHMP Opinion for ENFLONSIAâ,,g (clesrovimab) for the Prevention of RSV in Infants During Their First RSV Season. ...